6533b823fe1ef96bd127f7c4
RESEARCH PRODUCT
Are the serum levels of sCD40L modified by raloxifene in postmenopausal women?
Pilar J. OviedoJuan J. TarínAntonio CanoSusana NovellaCarlos Ehermenegildosubject
Selective Estrogen Receptor Modulatorsmedicine.medical_specialtyPostmenopausal womenbusiness.industryObstetricsCD40 LigandObstetrics and GynecologyMiddle AgedReproductive MedicineRaloxifene HydrochloridemedicineHumansRaloxifeneFemalebusinessOsteoporosis Postmenopausalmedicine.drug| year | journal | country | edition | language |
|---|---|---|---|---|
| 2008-10-01 | European journal of obstetrics, gynecology, and reproductive biology |